Innovative Therapies in Ewing Sarcoma

Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in anatomic pathology 2014-01, Vol.21 (1), p.49-67
Hauptverfasser: Amaral, Ana Teresa, Ordóñez, José Luis, Otero-Motta, Ana Pastora, García-Domínguez, Daniel J, Sevillano, María Victoria, de Álava, Enrique
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 67
container_issue 1
container_start_page 49
container_title Advances in anatomic pathology
container_volume 21
creator Amaral, Ana Teresa
Ordóñez, José Luis
Otero-Motta, Ana Pastora
García-Domínguez, Daniel J
Sevillano, María Victoria
de Álava, Enrique
description Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.
doi_str_mv 10.1097/PAP.0000000000000003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1466377102</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1466377102</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4036-14382ffb2469f1953c2b57c10799d8088107b5a8d2e7a53927a306d621b9bb7c3</originalsourceid><addsrcrecordid>eNpdkEtLAzEQx4Motj6-gcheBC9bM0k22RxLqVooWLCeQ7Kbtav7qMlui9_elFZF5zJz-D-GH0JXgEeApbhbjBcj_HfoERpCQmnMMIXjcGNBYhbUA3Tm_RvGQASHUzQgjAKXgIfoZtY07UZ35cZGy5V1el1aH5VNNN2WzWv0rF3W1voCnRS68vbysM_Ry_10OXmM508Ps8l4HmehkcfAaEqKwhDGZQEyoRkxicjCG1LmKU7TcJlEpzmxQidUEqEp5jknYKQxIqPn6Hafu3btR299p-rSZ7aqdGPb3itgnFMhAJMgZXtp5lrvnS3U2pW1dp8KsNoBUgGQ-g8o2K4PDb2pbf5j-ibym7ttq846_171W-vUyuqqW6kdwoSlOCYYGIYQGe9yOf0CF_Rsxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1466377102</pqid></control><display><type>article</type><title>Innovative Therapies in Ewing Sarcoma</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>Amaral, Ana Teresa ; Ordóñez, José Luis ; Otero-Motta, Ana Pastora ; García-Domínguez, Daniel J ; Sevillano, María Victoria ; de Álava, Enrique</creator><creatorcontrib>Amaral, Ana Teresa ; Ordóñez, José Luis ; Otero-Motta, Ana Pastora ; García-Domínguez, Daniel J ; Sevillano, María Victoria ; de Álava, Enrique</creatorcontrib><description>Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.</description><identifier>ISSN: 1072-4109</identifier><identifier>EISSN: 1533-4031</identifier><identifier>DOI: 10.1097/PAP.0000000000000003</identifier><identifier>PMID: 24316910</identifier><language>eng</language><publisher>United States: by Lippincott Williams &amp; Wilkins</publisher><subject>Animals ; Bone Neoplasms - genetics ; Bone Neoplasms - therapy ; Disease Models, Animal ; Humans ; Molecular Targeted Therapy - methods ; Sarcoma, Ewing - genetics ; Sarcoma, Ewing - therapy ; Therapies, Investigational</subject><ispartof>Advances in anatomic pathology, 2014-01, Vol.21 (1), p.49-67</ispartof><rights>2014 by Lippincott Williams &amp; Wilkins.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4036-14382ffb2469f1953c2b57c10799d8088107b5a8d2e7a53927a306d621b9bb7c3</citedby><cites>FETCH-LOGICAL-c4036-14382ffb2469f1953c2b57c10799d8088107b5a8d2e7a53927a306d621b9bb7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24316910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amaral, Ana Teresa</creatorcontrib><creatorcontrib>Ordóñez, José Luis</creatorcontrib><creatorcontrib>Otero-Motta, Ana Pastora</creatorcontrib><creatorcontrib>García-Domínguez, Daniel J</creatorcontrib><creatorcontrib>Sevillano, María Victoria</creatorcontrib><creatorcontrib>de Álava, Enrique</creatorcontrib><title>Innovative Therapies in Ewing Sarcoma</title><title>Advances in anatomic pathology</title><addtitle>Adv Anat Pathol</addtitle><description>Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.</description><subject>Animals</subject><subject>Bone Neoplasms - genetics</subject><subject>Bone Neoplasms - therapy</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>Molecular Targeted Therapy - methods</subject><subject>Sarcoma, Ewing - genetics</subject><subject>Sarcoma, Ewing - therapy</subject><subject>Therapies, Investigational</subject><issn>1072-4109</issn><issn>1533-4031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtLAzEQx4Motj6-gcheBC9bM0k22RxLqVooWLCeQ7Kbtav7qMlui9_elFZF5zJz-D-GH0JXgEeApbhbjBcj_HfoERpCQmnMMIXjcGNBYhbUA3Tm_RvGQASHUzQgjAKXgIfoZtY07UZ35cZGy5V1el1aH5VNNN2WzWv0rF3W1voCnRS68vbysM_Ry_10OXmM508Ps8l4HmehkcfAaEqKwhDGZQEyoRkxicjCG1LmKU7TcJlEpzmxQidUEqEp5jknYKQxIqPn6Hafu3btR299p-rSZ7aqdGPb3itgnFMhAJMgZXtp5lrvnS3U2pW1dp8KsNoBUgGQ-g8o2K4PDb2pbf5j-ibym7ttq846_171W-vUyuqqW6kdwoSlOCYYGIYQGe9yOf0CF_Rsxg</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>Amaral, Ana Teresa</creator><creator>Ordóñez, José Luis</creator><creator>Otero-Motta, Ana Pastora</creator><creator>García-Domínguez, Daniel J</creator><creator>Sevillano, María Victoria</creator><creator>de Álava, Enrique</creator><general>by Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201401</creationdate><title>Innovative Therapies in Ewing Sarcoma</title><author>Amaral, Ana Teresa ; Ordóñez, José Luis ; Otero-Motta, Ana Pastora ; García-Domínguez, Daniel J ; Sevillano, María Victoria ; de Álava, Enrique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4036-14382ffb2469f1953c2b57c10799d8088107b5a8d2e7a53927a306d621b9bb7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Bone Neoplasms - genetics</topic><topic>Bone Neoplasms - therapy</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>Molecular Targeted Therapy - methods</topic><topic>Sarcoma, Ewing - genetics</topic><topic>Sarcoma, Ewing - therapy</topic><topic>Therapies, Investigational</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amaral, Ana Teresa</creatorcontrib><creatorcontrib>Ordóñez, José Luis</creatorcontrib><creatorcontrib>Otero-Motta, Ana Pastora</creatorcontrib><creatorcontrib>García-Domínguez, Daniel J</creatorcontrib><creatorcontrib>Sevillano, María Victoria</creatorcontrib><creatorcontrib>de Álava, Enrique</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Advances in anatomic pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amaral, Ana Teresa</au><au>Ordóñez, José Luis</au><au>Otero-Motta, Ana Pastora</au><au>García-Domínguez, Daniel J</au><au>Sevillano, María Victoria</au><au>de Álava, Enrique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Innovative Therapies in Ewing Sarcoma</atitle><jtitle>Advances in anatomic pathology</jtitle><addtitle>Adv Anat Pathol</addtitle><date>2014-01</date><risdate>2014</risdate><volume>21</volume><issue>1</issue><spage>49</spage><epage>67</epage><pages>49-67</pages><issn>1072-4109</issn><eissn>1533-4031</eissn><abstract>Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.</abstract><cop>United States</cop><pub>by Lippincott Williams &amp; Wilkins</pub><pmid>24316910</pmid><doi>10.1097/PAP.0000000000000003</doi><tpages>19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1072-4109
ispartof Advances in anatomic pathology, 2014-01, Vol.21 (1), p.49-67
issn 1072-4109
1533-4031
language eng
recordid cdi_proquest_miscellaneous_1466377102
source MEDLINE; Journals@Ovid Ovid Autoload
subjects Animals
Bone Neoplasms - genetics
Bone Neoplasms - therapy
Disease Models, Animal
Humans
Molecular Targeted Therapy - methods
Sarcoma, Ewing - genetics
Sarcoma, Ewing - therapy
Therapies, Investigational
title Innovative Therapies in Ewing Sarcoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A55%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Innovative%20Therapies%20in%20Ewing%20Sarcoma&rft.jtitle=Advances%20in%20anatomic%20pathology&rft.au=Amaral,%20Ana%20Teresa&rft.date=2014-01&rft.volume=21&rft.issue=1&rft.spage=49&rft.epage=67&rft.pages=49-67&rft.issn=1072-4109&rft.eissn=1533-4031&rft_id=info:doi/10.1097/PAP.0000000000000003&rft_dat=%3Cproquest_cross%3E1466377102%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1466377102&rft_id=info:pmid/24316910&rfr_iscdi=true